Michael W. Epperly
9Patents
3h-index
22Co-inventors
57Inventor score
Filing activity: Nov 14, 1990 → Feb 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5208008A | Regioselective chemical modification of monoclonal antibodies | Chemistry; Metallurgy | 6 | Expired |
| US9200035B2 | Bifunctional compounds | Chemistry; Metallurgy | 3 | Active |
| US10172795B2 | Formulations and carrier systems including compound interactive domains | Human Necessities | 3 | Active |
| US8748369B2 | Use of targeted nitroxide agents in bone healing | Human Necessities | 1 | Active |
| US8822541B2 | Use of targeted nitroxide agents in mitigating or treating radiation injury | Human Necessities | 1 | Active |
| US9546144B2 | Bifunctional compounds | Chemistry; Metallurgy | 1 | Active |
| US8883852B2 | Radioprotective agents | Human Necessities | 0 | Active |
| US10251860B2 | Compounds for bone healing | Chemistry; Metallurgy | 0 | Active |
| US9365597B2 | Mitochondria-targeted inhibitors of cytochrome c peroxidase for protection from apoptosis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.